Yuki Mukai

1.9k total citations · 2 hit papers
42 papers, 1.3k citations indexed

About

Yuki Mukai is a scholar working on Surgery, Epidemiology and Physiology. According to data from OpenAlex, Yuki Mukai has authored 42 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 10 papers in Epidemiology and 8 papers in Physiology. Recurrent topics in Yuki Mukai's work include Endometrial and Cervical Cancer Treatments (7 papers), Alzheimer's disease research and treatments (6 papers) and Nonmelanoma Skin Cancer Studies (6 papers). Yuki Mukai is often cited by papers focused on Endometrial and Cervical Cancer Treatments (7 papers), Alzheimer's disease research and treatments (6 papers) and Nonmelanoma Skin Cancer Studies (6 papers). Yuki Mukai collaborates with scholars based in Japan, United States and France. Yuki Mukai's co-authors include Tiffini Voss, James Kost, Pierre N. Tariot, Bruno Vellas, Michael Egan, Paul Aisen, Jeffrey L. Cummings, Erin Mahoney, Christine Furtek and Lyn Harper Mozley and has published in prestigious journals such as New England Journal of Medicine, Brain and Biological Psychiatry.

In The Last Decade

Yuki Mukai

38 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer’s Disease

2018 471 citations Michael Egan, James Kost et al. profile →
Randomized Trial of Verubecestat for Prodromal Alzheimer’s Disease

2019 380 citations Michael Egan, James Kost et al. profile →

Peers

Countries citing papers authored by Yuki Mukai

Since Specialization

Citations

This map shows the geographic impact of Yuki Mukai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuki Mukai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuki Mukai more than expected).

Fields of papers citing papers by Yuki Mukai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuki Mukai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuki Mukai. The network helps show where Yuki Mukai may publish in the future.

Co-authorship network of co-authors of Yuki Mukai

This figure shows the co-authorship network connecting the top 25 collaborators of Yuki Mukai. A scholar is included among the top collaborators of Yuki Mukai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuki Mukai. Yuki Mukai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Right vertebral artery arising from the extreme proximal right subclavian artery and entering the C3 transverse foramen diagnosed by magnetic resonance angiography 2025 ·Surgical and Radiologic Anatomy ·Akira Uchino, Yuki Mukai	0
2	Sugammadex for Reversal of Neuromuscular Blockade in Neonates and Infants Less than 2 Years Old: Results from a Phase IV Randomized Clinical Trial 2025 ·Anesthesiology ·Edith Mensah‐Osman, Yuki Mukai, (unknown), Maria Matuszczak, Vera Saldien, Heather Leibensperger, (unknown), (unknown), Rebecca E. Wrishko, Alison Gee, W. Joseph Herring	1
3	Effects of PDE10A inhibitor MK-8189 in people with an acute episode of schizophrenia: A randomized proof-of-concept clinical trial 2024 ·Schizophrenia Research ·Yuki Mukai, Robert Lupinacci, Stephen R. Marder, (unknown), Tiffini Voss, Sean M. Smith, Michael Egan	10
4	Serum concentrations of ketones increase after hand-ergometer exercise in persons with cervical spinal cord injuries: a preliminary prospective study 2022 ·Spinal Cord ·(unknown), (unknown), Jason S. Au, Yoshi‐ichiro Kamijo, (unknown), Yuki Mukai, Yasunori Umemoto, Ken Kouda, Takahiro Ogawa, Fumihiro Tajima	0
5	Dose-response Rehabilitation Organized By Pror In Out-patients With Chronic Cerebrovascular Disorder: A single-center retrospective cohort study 2022 ·Journal of Stroke and Cerebrovascular Diseases ·(unknown), Yoshi‐ichiro Kamijo, (unknown), Yasunori Umemoto, Yuki Mukai, Yukio Mikami, Ken Kouda, Takahiro Ogawa, Yukihide Nishimura, Fumihiro Tajima	3
6	Outcome of Radiation Therapy for Stage IVB Uterine Cervical Cancer With Distant Lymph Nodes Metastases; Sequential Irradiation for Distant Lymph Nodes Metastases 2021 ·In Vivo ·Yuki Mukai, Naho Yokota, (unknown), Taichi Mizushima, (unknown), Yuichi Imai, (unknown), (unknown), (unknown), Masaharu Hata	9
7	A randomized trial evaluating the safety profile of sugammadex in high surgical risk ASA physical class 3 or 4 participants 2021 ·BMC Anesthesiology ·W. Joseph Herring, Yuki Mukai, Aobo Wang, (unknown), (unknown), (unknown), (unknown), (unknown), Manfred Blobner	7
8	Treatment Outcome of the Combination Therapy of High-dose rate Intracavitary Brachytherapy and Intensity-modulated Radiation Therapy With Central-shielding for Cervical Cancer 2020 ·In Vivo ·Yuki Mukai, (unknown), Hiromi Inoue, Akiko Satô, (unknown), (unknown), Kazuya Onuma, (unknown), (unknown), (unknown), (unknown), Tomio Inoue, Masaharu Hata, Motoko Omura	3
9	Comparison between esophageal and intestinal temperature responses to upper-limb exercise in individuals with spinal cord injury 2019 ·Spinal Cord ·Jason S. Au, Yoshi‐ichiro Kamijo, Victoria L. Goosey‐Tolfrey, Christof A. Leicht, Maureen J. MacDonald, Yuki Mukai, Fumihiro Tajima	10
10	Outcomes of treatment for localized prostate cancer in a single institution: comparison of radical prostatectomy and radiation therapy by propensity score matching analysis 2019 ·World Journal of Urology ·Narihiko Hayashi, Kimito Osaka, (unknown), Hisashi Hasumi, Kazuhide Makiyama, Keiichi Kondo, Noboru Nakaigawa, Masahiro Yao, Yuki Mukai, (unknown), Shoko Takano, Eiko Ito, (unknown), Izumi Koike, Masaharu Hata, Masataka Taguri, Yasuhide Miyoshi, Koji Izumi, Takashi Kawahara, Hiroji Uemura	13
11	Radiation Therapy for Uterine Cervical Cancer With Lung Metastases Including Oligometastases 2019 ·In Vivo ·Yuki Mukai, Izumi Koike, Tatsuya Matsunaga, Naho Yokota, (unknown), (unknown), (unknown), Etsuko Miyagi, Masaharu Hata	8
12	Outcome of Radiation Therapy for Locally Advanced Vulvar Carcinoma: Analysis of Inguinal Lymph Node 2019 ·In Vivo ·Yuki Mukai, Izumi Koike, Tatsuya Matsunaga, Naho Yokota, (unknown), Shoko Takano, (unknown), Eiko Ito, Etsuko Miyagi, Masaharu Hata	2
13	Further analyses of the safety of verubecestat in the phase 3 EPOCH trial of mild-to-moderate Alzheimer’s disease 2019 ·Alzheimer s Research & Therapy ·Michael Egan, Yuki Mukai, Tiffini Voss, James Kost, Julie A. Stone, Christine Furtek, Erin Mahoney, Jeffrey L. Cummings, Pierre N. Tariot, Paul Aisen, Bruno Vellas, Christopher Lines, David Michelson	63
14	Radiation Therapy for Patients with Bone Metastasis from Uterine Cervical Cancer: Its Role and Optimal Radiation Regimen for Palliative Care 2018 ·Anticancer Research ·Masaharu Hata, Izumi Koike, Etsuko Miyagi, Mikiko Asai‐Sato, (unknown), Yuki Mukai, Shoko Takano, Eiko Ito, (unknown), Tomio Inoue	14
15	Tangent field technique of TomoDirect improves dose distribution for whole‐breast irradiation 2015 ·Journal of Applied Clinical Medical Physics ·(unknown), Motoko Omura, (unknown), Yuki Mukai, (unknown), (unknown), (unknown), Miwa Yoshida	8
16	Radiation therapy with concurrent retrograde superselective intra-arterial chemotherapy for gingival carcinoma 2013 ·Strahlentherapie und Onkologie ·Yuki Mukai, Masaharu Hata, Kenji Mitsudo, Izumi Koike, Toshiyuki Koizumi, Senri Oguri, Mitomu Kioi, Motoko Omura, Iwai Tohnai, Tomio Inoue	8
17	Radiation therapy for extramammary Paget's disease: treatment outcomes and prognostic factors 2013 ·Annals of Oncology ·Masaharu Hata, Izumi Koike, Hidefumi Wada, (unknown), (unknown), (unknown), (unknown), Yuki Mukai, Eiko Ito, Tomio Inoue	31
18	Radiation therapy for primary carcinoma of the eyelid: tumor control and visual function 2012 ·Strahlentherapie und Onkologie ·Masaharu Hata, Izumi Koike, Jiro Maegawa, Akihiro Kaneko, Kazumasa Odagiri, (unknown), (unknown), (unknown), Yuki Mukai, Tomio Inoue	9
19	Treatment of depression in the elderly: A review of the recent literature on the efficacy of single- versus dual-action antidepressants 2009 ·Clinical Therapeutics ·Yuki Mukai, Rajesh R. Tampi	41
20	Fatal reactivation of hepatitis B virus following cytotoxic chemotherapy for acute myelogenous leukemia: fibrosing cholestatic hepatitis 2002 ·European Journal Of Haematology ·Hideo Kojima, Masato Abei, Nobuyuki Takei, Yuki Mukai, Yasuhiro Hasegawa, Tatsuo Iijima, Toshiro Nagasawa	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact